shares of iRhythm Technologies Inc (IRTC) on
iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. The company is headquartered in San Francisco, California and currently employs 748 full-time employees. The firm develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The firm offers flagship solution, the ZIO Service. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its ZIO Report produces a higher diagnostic yield and to change patient management. The Company’s Zio service combines a wire-free, patch-based, wearable biosensor with a proprietary cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.